Financial Statements · Financial Reporting
osaühing TBD Pharmatech
Official identifier 11204964Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 17 Jun 2025
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 11,731,557 |
| Balance sheet | Cash and cash equivalents | 2,388,297 |
| Balance sheet | Current assets | 4,813,768 |
| Balance sheet | Current liabilities | 1,401,262 |
| Balance sheet | Equity | 6,330,295 |
| Balance sheet | Share capital at nominal value | 7,136 |
| Balance sheet | Non-current assets | 6,917,789 |
| Balance sheet | Non-current liabilities | 4,000,000 |
| Balance sheet | Retained earnings (loss) from previous periods | 4,333,835 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -189,840 |
| Income statement scheme 1 | Labour costs | -2,400,332 |
| Income statement scheme 1 | Revenue | 6,286,179 |
| Income statement scheme 1 | Annual period profit / loss | 1,450,675 |
| Income statement scheme 1 | Operating profit (loss) | 1,435,811 |
| Income statement scheme 1 | Profit (loss) before income tax | 1,450,675 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 4,333,835 |
| Note: Labour costs | Employees | 58 |
| Note: Labour costs | Labour costs | -2,400,332 |
| Rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 189,840 |
| Rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 1,435,811 |
Linked company
Company: osaühing TBD Pharmatech